LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Meir Medical Center
Kfar Saba, IsraelPublicaciones en colaboración con investigadores/as de Meir Medical Center (2)
2024
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816
2012
-
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 30, Núm. 25, pp. 3084-3092